ATAD2 overexpression links to enrichment of B-MYB-translational signatures and development of aggressive endometrial carcinoma.

Oncotarget · 2015 · PMC4695070 · PMID 26308378

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

To explore ATAD2 alterations in detail for endometrial cancer, putative copy-number alterations (GISTIC-based analysis [ 17 ]), showed a highly significant correlation of increased copy-number levels and mRNA expression of ATAD2 for endometrial cancer, confirming previous findings that ATAD2 amplification leads to higher expression of ATAD2 ( Supplementary Figure S1A ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.